Prognostic Value of PlGF Upregulation in Prostate Cancer
These findings suggest that PlGF contributes to an immunosuppressive environment, thus favoring tumor progression and metastatic process. Results here highlight the potential of integrating these molecular markers with existing prognostic tools to enhance the accuracy of metastasis prediction in PCa. By identifying patients at risk for metastasis, clinicians can tailor treatment strategies more effectively, potentially improving survival outcomes and quality of life. This study underscores the importance of further research into the role of intratumoral biomarkers in PCa management.
Authors
- Erica Giacobbi (ORCID: https://orcid.org/0000-0002-2582-3527)
- Valeria Palumbo (ORCID: https://orcid.org/0000-0001-7756-6676)
- Loredana Albonici (ORCID: https://orcid.org/0000-0001-5037-4551)
- Francesca Servadei (ORCID: https://orcid.org/0000-0003-2619-9153)
- Simone Albisinni (ORCID: https://orcid.org/0000-0001-5529-3064)
- Manuel Scimeca (ORCID: https://orcid.org/0000-0003-0585-1309)
- Camilla Palumbo (ORCID: https://orcid.org/0000-0001-5087-7140)
- Enrico Finazzi Agrò (ORCID: https://orcid.org/0000-0002-0308-8824)
- Alessandro Mauriello (ORCID: https://orcid.org/0000-0002-7351-5676)
Institutions
- University of Rome Tor Vergata (IT)
- Catholic University Our Lady of Good Counsel (AL)
Publication Details
- Journal
- Biomedicines
- Published
- 2024-09-26
- DOI
- https://doi.org/10.3390/biomedicines12102194
- Primary Topic
- Prostate Cancer Treatment and Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00